Real-world supported unprotected left main percutaneous coronary intervention with impella device; data from the USpella registry.
Theodore SchreiberWah Wah HtunNimrod BlankTesfaye TelilaNestor MercadoAlexandros BriasoulisAmir KakiAshok KondurAhmad MunirCindy GrinesPublished in: Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions (2017)
This large singe center retrospective evaluation of USpella registry substantiates and strongly supports the feasibility, safety, and hemodynamic usefulness of Impella device for ULMI with acceptable in-hospital and 30-day MACE rates. © 2017 Wiley Periodicals, Inc.
Keyphrases
- percutaneous coronary intervention
- extracorporeal membrane oxygenation
- st segment elevation myocardial infarction
- acute coronary syndrome
- acute myocardial infarction
- coronary artery disease
- left ventricular assist device
- healthcare
- electronic health record
- st elevation myocardial infarction
- antiplatelet therapy
- cross sectional
- coronary artery bypass grafting
- big data
- heart failure
- atrial fibrillation
- adverse drug
- machine learning
- emergency department
- acute care
- coronary artery bypass
- left ventricular